Skip to main content
Public Health

Medical Countermeasures Strategy

We are working on a new Strategy for Medical Countermeasures. Find out what’s happening, why it matters and how you can have your say.

What the Commission is doing

The European Commission is preparing a new Strategy for Medical Countermeasures, to be adopted in 2025. The strategy, announced by President Ursula von der Leyen in her political guidelines and included in the Preparedness Union Strategy, will identify key measures to further accelerate innovation and supply of medical countermeasures. 

Medical countermeasures encompass vaccines, therapeutics, diagnostics, and personal protective equipment (PPE). They play a vital role to enhance our protection from current and future health emergencies, including those arising from infectious disease outbreaks, antimicrobial resistance (AMR), chemical, biological, radiological or nuclear (CBRN) threats, or other large-scale cross-border emergencies. 

Why the strategy is needed

The upcoming strategy will set out how to advance at EU level the development and availability of medical countermeasures and high-value technologies relevant for our health security. 

Overall, the strategy aims to help improve the EU’s preparedness, security and strategic autonomy, while also accelerating innovation in sectors which are key for Europeans’ health and well-being and for the competitiveness of our economy. 

How to get involved

We want your input.

You can help shape the future of health security in Europe by sharing your feedback through our Call for Evidence on the Have Your Say portal. The call is open until 9 May 2025.

Don’t miss the opportunity to help design the Medical Countermeasures Strategy in a collaborative, transparent and inclusive way.

Share your feedback